X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19) 19
index medicus (17) 17
female (13) 13
human papillomavirus (11) 11
papillomavirus infections - prevention & control (10) 10
vaccines (9) 9
papillomavirus vaccines - administration & dosage (8) 8
uterine cervical neoplasms - prevention & control (8) 8
analysis (7) 7
cost-benefit analysis (7) 7
male (7) 7
papillomavirus infections (7) 7
vaccination (7) 7
adolescent (6) 6
child (6) 6
cost-effectiveness (6) 6
immunology (6) 6
oncology (6) 6
papillomavirus vaccines - immunology (6) 6
women (6) 6
adult (5) 5
canada (5) 5
cervical cancer (5) 5
economic-evaluation (5) 5
gene expression (5) 5
genital warts (5) 5
infectious diseases (5) 5
papillomavirus infections - epidemiology (5) 5
papillomavirus vaccines - economics (5) 5
quality-adjusted life years (5) 5
research (5) 5
sexual behavior (5) 5
abridged index medicus (4) 4
bivalent (4) 4
brain (4) 4
comparative analysis (4) 4
epidemiology (4) 4
genomes (4) 4
health aspects (4) 4
hpv vaccination (4) 4
immunization (4) 4
mathematical modeling (4) 4
medical research (4) 4
microbiology (4) 4
papillomavirus infections - complications (4) 4
papillomavirus infections - economics (4) 4
papillomavirus infections - transmission (4) 4
papillomavirus infections - virology (4) 4
public health (4) 4
public, environmental & occupational health (4) 4
quadrivalent (4) 4
united-states (4) 4
uterine cervical neoplasms - epidemiology (4) 4
uterine cervical neoplasms - virology (4) 4
allergy and immunology (3) 3
anogenital warts (3) 3
bioinformatics (3) 3
care and treatment (3) 3
condylomata acuminata - epidemiology (3) 3
condylomata acuminata - prevention & control (3) 3
developed-countries (3) 3
efficacy (3) 3
hpv vaccine (3) 3
immunization schedule (3) 3
immunogenicity (3) 3
incidence (3) 3
intraepithelial neoplasia (3) 3
major and brief reports (3) 3
major articles and brief reports (3) 3
medicine, research & experimental (3) 3
methods (3) 3
models (3) 3
models, biological (3) 3
models, economic (3) 3
models, statistical (3) 3
natural-history (3) 3
papillomaviruses (3) 3
reporter gene (3) 3
risk factors (3) 3
transgenic mice (3) 3
united states (3) 3
vaccination - economics (3) 3
young adult (3) 3
adolescents (2) 2
animals (2) 2
anticancer drug-delivery (2) 2
bacteria (2) 2
biochemistry & molecular biology (2) 2
biocompatibility (2) 2
biodistribution (2) 2
brain - metabolism (2) 2
canada - epidemiology (2) 2
cancer-therapy (2) 2
cells (2) 2
cervical cancers (2) 2
cervical intraepithelial neoplasia (2) 2
cervical intraepithelial neoplasia - epidemiology (2) 2
cervical intraepithelial neoplasia - prevention & control (2) 2
cervical intraepithelial neoplasia - virology (2) 2
computational biology (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the National Cancer Institute, ISSN 0027-8874, 01/2016, Volume 108, Issue 1, p. djv282
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2012, Volume 104, Issue 22, pp. 1712 - 1723
Background Bivalent and quadrivalent human papillomavirus (HPV) vaccines are now licensed in several countries. Furthermore, clinical trials examining the... 
AGED 16-26 YEARS | COST-EFFECTIVENESS | ECONOMIC-EVALUATION | ONCOLOGY | PARTICLE VACCINE | FOLLOW-UP | GENITAL WARTS | NATURAL-HISTORY | NONVACCINE HPV TYPES | CERVICAL INTRAEPITHELIAL NEOPLASIA | DEVELOPED-COUNTRIES | Humans | Middle Aged | Uterine Cervical Neoplasms - epidemiology | Condylomata Acuminata - virology | Condylomata Acuminata - epidemiology | Male | Condylomata Acuminata - prevention & control | Incidence | Young Adult | Canada - epidemiology | Uterine Cervical Dysplasia - virology | Adult | Female | Cervical Intraepithelial Neoplasia - epidemiology | Uterine Cervical Dysplasia - epidemiology | Child | Papillomavirus Vaccines - administration & dosage | Papillomavirus Infections - transmission | Papillomavirus Infections - complications | Sexual Behavior | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Models, Statistical | Uterine Cervical Dysplasia - prevention & control | Cervical Intraepithelial Neoplasia - virology | Mass Screening | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Complications and side effects | Care and treatment | Squamous cell carcinoma | Cervix dysplasia | Vaccines | Research | Health aspects | Papillomavirus infections | Risk factors
Journal Article
American Journal of Epidemiology, ISSN 0002-9262, 2016, Volume 184, Issue 12, pp. 873 - 883
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 01/2016, Volume 108, Issue 1, p. 1
  Randomized clinical trials have shown the 9-valent human papillomavirus (HPV) vaccine to be highly effective against types 31/33/45/52/58 compared with the... 
Human papillomavirus | Immunization | Uncertainty | Effectiveness | Economic impact | Comparative analysis
Journal Article
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2014, Volume 134, Issue 9, pp. 2264 - 2268
Journal Article
Journal Article
Applied Mathematics, ISSN 2152-7385, 2015, Volume 6, Issue 8, pp. 1407 - 1425
Journal Article
Vaccine, ISSN 0264-410X, 2013, Volume 31, Issue 37, pp. 3863 - 3871
Highlights • Vaccinating girls against HPV is predicted to be highly cost-effective. • The most cost-effective vaccine will be determined by their relative... 
Allergy and Immunology | Economic analysis | Mathematical modeling | HPV vaccination | Cost-effectiveness | Cervical cancer | MEDICINE, RESEARCH & EXPERIMENTAL | UTILITY ANALYSIS | IMMUNIZATION PROGRAMS | IMMUNOLOGY | INTRAEPITHELIAL NEOPLASIA | CROSS-PROTECTION | ECONOMIC-EVALUATION | PARTICLE VACCINE | CERVICAL-CANCER PREVENTION | GENITAL WARTS | SQUAMOUS-CELL CARCINOMAS | NONVACCINE HPV TYPES | Humans | Condylomata Acuminata - virology | Male | Models, Economic | Condylomata Acuminata - prevention & control | Vaccination - methods | Uterine Cervical Neoplasms - economics | Condylomata Acuminata - economics | Female | Oropharyngeal Neoplasms - economics | Child | Papillomavirus Vaccines - administration & dosage | Papillomavirus Infections - transmission | Models, Theoretical | Quality-Adjusted Life Years | Vaccination - economics | Papillomavirus Vaccines - economics | Sexual Behavior | Costs and Cost Analysis | Uterine Cervical Neoplasms - prevention & control | Oropharyngeal Neoplasms - virology | Papillomavirus Infections - economics | Canada | Cost-Benefit Analysis | Uterine Cervical Neoplasms - virology | Oropharyngeal Neoplasms - prevention & control | Warts | Medical research | Vaccination | Medicine, Experimental | Models | Vaccines | Comparative analysis | Papillomavirus infections | Public health | Papillomaviruses | Health care industry | Medical care, Cost of | Human papillomavirus | Discount rates
Journal Article